Miyako Capital

Oishii Farm, founded in 2017 by Hiroki Koga and Brendan Somerville, specializes in indoor vertical farming technology with a focus on cultivating strawberries at a commercial scale. The company offers pesticide-free strawberries, packaged in containers of eight to eleven, and sold at supermarkets for approximately $50 per package. Oishii's innovative farming approach allows for year-round production of local and sustainable produce, addressing environmental challenges by significantly reducing water usage and increasing crop yields. This method enables cultivation in various locations worldwide, aligning with contemporary agricultural demands for sustainability and efficiency.

Peds3 is a digital healthcare platform that specializes in the research and development of pediatric medicine and maternal and child health fields.

Innovative Space Carrier is a aerospace company that offers space transportation systems, planning, drafting and technology strategies.

Sakana AI is an research company focused on creating innovative foundation models inspired by nature. The organization emphasizes evolution and collective intelligence in its AI development processes.

Orange is a developer of a variety of deep-learning models with a focus on computer vision and natural language processing for comics.

Oishii Farm, founded in 2017 by Hiroki Koga and Brendan Somerville, specializes in indoor vertical farming technology with a focus on cultivating strawberries at a commercial scale. The company offers pesticide-free strawberries, packaged in containers of eight to eleven, and sold at supermarkets for approximately $50 per package. Oishii's innovative farming approach allows for year-round production of local and sustainable produce, addressing environmental challenges by significantly reducing water usage and increasing crop yields. This method enables cultivation in various locations worldwide, aligning with contemporary agricultural demands for sustainability and efficiency.

Esa is an environment solutions company that engages in plastic waste recycling, product creation, and distribution services.

LocationMind Co., Ltd. is an IT company based in Chiyoda, Japan, founded in 2019. It develops artificial intelligence-based software solutions focused on human flow analysis, utilizing big data and spatial information engineering. The company offers products such as LocationMind xPop, a SaaS dashboard for a variety of people flow analysis needs, and MobMap, a tool for analyzing human flow data over time. By leveraging AI models, LocationMind provides insights into people density, movement patterns, and transport modes, serving a diverse range of industries and institutions. Its solutions are designed to enhance the understanding of human flow dynamics, critical for various applications in next-generation technology.

Sakana AI is an research company focused on creating innovative foundation models inspired by nature. The organization emphasizes evolution and collective intelligence in its AI development processes.

Galdieria is a biotechnology company providing urban mining recycling, precious metals absorbent, cleantech, and energy-related services.

Helpfeel is a technology company focused on human empowerment through knowledge delivery. It offers tools that facilitate access to information, including Frequently Asked Questions (FAQs), internal knowledge searches, and product recommendations. Helpfeel's platform allows users to refine and connect ideas, helping them find answers efficiently. The company aims to enhance user experience by simplifying the search for information, thereby fostering better understanding and communication. Established with a vision to improve knowledge accessibility, Helpfeel continues to innovate in the realm of information technology.

SocialGood, Inc. operates the SocialGood App, a platform designed to provide financial freedom to users by enabling them to earn cryptocurrency rewards while shopping online. With over 2.3 million users across more than 200 countries, the app partners with over 20,000 major shopping websites, allowing users to earn SocialGood cryptocurrency based on their spending. The app features a unique Crypto Back system, for which the company has registered 68 patents in Japan. By utilizing this application, users can accumulate assets through their online purchases, supporting SocialGood's mission to establish a global financial ecosystem that benefits individuals worldwide.

Viage Therapeutics is a neuroscience company established in 2018, focused on developing innovative neurotherapeutics. The company aims to address psychiatric and inflammatory diseases by discovering and creating a new class of drugs targeting conditions such as depression, anxiety, and gastrointestinal disorders. Through its groundbreaking research, Viage Therapeutics seeks to provide researchers and healthcare professionals with access to novel treatments for significant unmet medical needs in these areas.

VLP Therapeutics, LLC, founded in 2012 by experienced biopharmaceutical professionals, is dedicated to developing innovative medical treatments that enhance traditional vaccine and targeted antibody therapies. Headquartered in Gaithersburg, Maryland, the company focuses on addressing global unmet medical needs through its next-generation inserted alpha VLP (i-αVLP) technology. This approach aims to combat significant public health challenges of the 21st century, enabling healthcare providers to effectively treat cancer, infectious diseases, and autoimmune disorders.

ALGO ARTIS is a software company that specializes in optimizing various aspects of operational management, including plant operations, tanking, ship allocation planning, and logistics. The company employs algorithmic methods and artificial intelligence technology to enhance efficiency in social infrastructure management. By focusing on the selection of appropriate technologies and processes, ALGO ARTIS enables businesses to streamline operations, thereby improving overall performance and effectiveness.

VividQ Limited is a software company specializing in the development of a framework that enables the generation, compression, and transmission of 3D holographic images and video. The company offers several key products, including VividQ Capture, which standardizes 3D data for holographic display, and VividQ Squeeze, a compression solution for point cloud data storage. Additionally, VividQ Core facilitates multi-user interactions with holograms, while VividQ View allows developers to integrate various spatial light modulators into their systems. The company's technology is utilized across various sectors, including consumer electronics, augmented and virtual reality, automotive displays, and immersive simulations. Founded in 2015 and based in Cambridge, United Kingdom, VividQ collaborates with leading original equipment manufacturers to integrate its advanced software and hardware solutions into next-generation consumer devices, aiming to create a seamless blend of real and virtual experiences.

Startbahn, Inc. is a Tokyo-based company founded in 2014 that focuses on enhancing the art experience in the digital era. It operates a platform designed for artists and those involved in the art community, providing essential technological support. Startbahn is developing Startbahn Cert., a service that utilizes blockchain technology to issue certificates for artworks, which helps ensure authenticity and provenance. The company also promotes Startrail, a blockchain infrastructure that underpins Startbahn Cert. Additionally, Startbahn offers a certificate management system that allows users to access registration information via smartphone and provides a marketplace for buyers to discover artworks. Through these services, Startbahn aims to facilitate the management of art collections and improve the overall accessibility and integrity of the art market.

VLP Therapeutics, LLC, founded in 2012 by experienced biopharmaceutical professionals, is dedicated to developing innovative medical treatments that enhance traditional vaccine and targeted antibody therapies. Headquartered in Gaithersburg, Maryland, the company focuses on addressing global unmet medical needs through its next-generation inserted alpha VLP (i-αVLP) technology. This approach aims to combat significant public health challenges of the 21st century, enabling healthcare providers to effectively treat cancer, infectious diseases, and autoimmune disorders.

Hacarus Inc. is a technology company based in Kyoto, Japan, that specializes in artificial intelligence solutions for the manufacturing and medical sectors. Established in 2014, Hacarus develops products that leverage its proprietary Sparse Modeling technology, which allows for efficient data analysis and decision-making. The company offers several key platforms, including SALUS, which caters to medical and life sciences applications, and COLIGO, a customizable application that supports various implementations in IoT and edge computing. Additionally, Hacarus provides SPECTRO, a tool for enhanced visual inspections, and offers data science consulting services along with an AI Academy for education in AI technologies. By focusing on small data and resource-efficient solutions, Hacarus aims to deliver insights that enable faster and more reliable decision-making compared to traditional deep learning approaches.

Floadia Corporation, established in 2011 and headquartered in Tokyo, Japan, specializes in the development, licensing, and sale of semiconductor intellectual property, particularly focusing on embedded non-volatile memory solutions. The company leverages its engineering team's extensive experience in embedded FLASH technology, which includes contributions from pioneers in the field. Floadia's technology is designed for use in various applications, including Internet of Things devices, automobiles, smartphones, and smart cards. Their embedded memory solutions offer low-power consumption and cost efficiency, while also providing durability suitable for automotive-grade environments. In addition to its product offerings, Floadia provides technology consulting services to support its clients in optimizing their semiconductor needs.

Varinos Inc. is a clinical testing company based in Tokyo, Japan, founded in 2017. It specializes in genomic testing and continuous clinical sequencing services, offering innovative solutions such as endometrial microbiome testing and the analysis of intrauterine flora. By leveraging next-generation sequencing technology, Varinos partners with medical institutions to provide advanced contract analysis services. The company's genome analysis technology enables the detection of microscopic amounts of bacteria, facilitating the examination and diagnosis of genetic abnormalities in embryos prior to pregnancy. This approach aims to alleviate both physical and mental burdens for women seeking reproductive health solutions.

CellAxia Inc., founded in 2017 and based in Tokyo, Japan, is a biotechnology startup focused on developing cell therapy drugs. The company aims to transform advanced research into practical applications in the healthcare sector, specifically targeting intractable autoimmune diseases. CellAxia specializes in the discovery, development, and commercialization of biological therapies, enabling researchers to utilize challenging cell types, such as primary and cancer stem cell cultures. Through its innovative approach, CellAxia seeks to create new therapeutic cell-based treatments, addressing unmet medical needs in the field of cell therapy.

BizteX, Inc. is a software company based in Tokyo, Japan, specializing in cloud-based robotic process automation (RPA) solutions. Founded in 2015, the company develops software designed to automate routine operations through its flagship product, BizteX Cobit. This digital robot utilizes artificial intelligence to execute repetitive tasks, allowing businesses to streamline their operations and focus on more creative and strategic activities. By offering its services globally, BizteX aims to enhance productivity and efficiency for various organizations, enabling them to optimize their resources effectively.

Liberaware Co Ltd is focused on the development and application of non-GPS small drones designed for industrial purposes. The company offers a range of services, including inspection services, drone rentals, and sales. Its flagship product is the "IBIS" indoor confined-space inspection drone, which is equipped with advanced IoT and AI capabilities. In addition to drone hardware, Liberaware provides video editing services and solutions for processing and analyzing data collected by its drones and other equipment. Through these offerings, the company aims to enhance operational efficiency and safety in various industrial applications.

Goryo Chemical, Inc. is a company based in Sapporo, Japan, with an additional office in Tokyo, that specializes in the development and sales of fluorescent probes and functional dyes for chemical biology and bio applications. Founded in 2010, the company offers a range of products and services, including AcidiFluor, CalFluor, GlycoFluor, ProteoFluor, MetalloFluor, ROSFluor, and IndoCyanine green dye series, as well as bioluminescent probes and custom synthesis services. These probes are designed for cellular analysis, assay, and imaging, allowing for selective staining of acidic organelles like lysosomes and late endosomes, which can aid in medical diagnostics and treatment. Goryo Chemical serves a diverse customer base through a network of distributors both in Japan and internationally.

Integral Geometry Science Inc., founded in 2012 and based in Kobe, Japan, specializes in the design and development of advanced measurement devices and software for image data processing. The company focuses on the inverse analysis theory of electromagnetic and scattered fields, producing high-performance measurement systems that utilize multi-path scattered field theory. Integral Geometry Science is particularly noted for its microwave mammography system, which addresses challenges in imaging high-density breast tissue. This innovative technology improves the clarity of images, allowing for accurate differentiation between cancerous and normal tissue, thus reducing the need for painful and radiation-exposing conventional screening methods. Additionally, the company manufactures nondestructive inspection systems for lithium-ion batteries, contributing to safety and reliability in battery technology.

Atomis Inc. specializes in the manufacture of porous coordination polymers (PCPs), also known as metal-organic frameworks (MOFs), which are utilized for precise gas control and separation. Founded in 2015 and headquartered in Kyoto, Japan, the company focuses on the evaluation, synthesis, and production of these materials to serve various applications, including gas transportation, molecular separations, and high-density storage. Atomis aims to enhance manufacturing processes and develop innovative applications for its products, which are grounded in research by Professor Susumu Kitagawa at Kyoto University. The company’s offerings support energy companies and environmental organizations in utilizing advanced technologies for distributed gas delivery and carbon dioxide reduction systems.

Integral Geometry Science Inc., founded in 2012 and based in Kobe, Japan, specializes in the design and development of advanced measurement devices and software for image data processing. The company focuses on the inverse analysis theory of electromagnetic and scattered fields, producing high-performance measurement systems that utilize multi-path scattered field theory. Integral Geometry Science is particularly noted for its microwave mammography system, which addresses challenges in imaging high-density breast tissue. This innovative technology improves the clarity of images, allowing for accurate differentiation between cancerous and normal tissue, thus reducing the need for painful and radiation-exposing conventional screening methods. Additionally, the company manufactures nondestructive inspection systems for lithium-ion batteries, contributing to safety and reliability in battery technology.

StemRIM is a biotechnology company based in Ibaraki, Japan, founded in 2006. The company specializes in the development of regeneration-guided medicines aimed at treating challenging diseases such as epidermolysis bullosa, cerebral infarction, and myocardial infarction. StemRIM's innovative approach involves mobilizing the body's own stem cells to target injured or diseased tissues without the need for extraction. Their product portfolio includes PJ1 regeneration induction medicine using HMGB1 peptides, PJ2 and PJ3 regeneration-inducing drugs and proteins, as well as the PJ4 therapeutic autologous cell collection device and PJ5 stem cell gene therapy technology. Through its research and development efforts, StemRIM seeks to advance the field of regenerative medicine and provide effective treatment options for patients with intractable conditions.

Hacarus Inc. is a technology company based in Kyoto, Japan, that specializes in artificial intelligence solutions for the manufacturing and medical sectors. Established in 2014, Hacarus develops products that leverage its proprietary Sparse Modeling technology, which allows for efficient data analysis and decision-making. The company offers several key platforms, including SALUS, which caters to medical and life sciences applications, and COLIGO, a customizable application that supports various implementations in IoT and edge computing. Additionally, Hacarus provides SPECTRO, a tool for enhanced visual inspections, and offers data science consulting services along with an AI Academy for education in AI technologies. By focusing on small data and resource-efficient solutions, Hacarus aims to deliver insights that enable faster and more reliable decision-making compared to traditional deep learning approaches.

ARTham Therapeutics Inc. is a biopharmaceutical company based in Naka-Ku, Japan, founded in 2018. The company is focused on developing innovative, disease-modifying medicines aimed at improving patient health. It offers a range of programs, including art-648, art-ep, art-pde, and art-001, targeting conditions such as inflammatory skin diseases, vascular malformations, and immuno-oncology endometriosis. ARTham operates a virtual research and development model that fosters collaboration with academic and business partners to drive innovation in drug development. Through its efforts, ARTham Therapeutics seeks to address specific medical needs, enhance patient recovery, and improve overall quality of life.

Trigence Semiconductor, Inc. is an audio integrated circuit design and solution provider based in Tokyo, Japan, with additional offices in the United States, Hong Kong, and Taiwan. Founded in 2006, the company specializes in developing digital audio products, including Digital Speaker Modules, which integrate speakers, enclosures, connectors, audio DSPs, and interfaces to meet the audio needs of PCs, tablets, and smartphones. Trigence's technology is designed to enhance audio quality for various consumer electronics, such as computers, headphones, soundbars, and Bluetooth speakers, while ensuring efficient power consumption. The company's products are distributed through various channels, catering to the consumer and IT markets. Trigence is recognized for its innovative algorithms that control speaker response, allowing users to experience high-quality audio in a range of applications.

Megakaryon Corporation is a medical research company based in Kyoto, Japan, with an additional office in Tokyo. Founded in 2011, it specializes in the development of blood products, particularly platelets and red blood cells, derived from human induced pluripotent stem (iPS) cell lines. The company focuses on creating transfusion medicine technologies that allow medical practitioners to maintain patients' platelet counts without relying on traditional blood donations. Megakaryon's innovative approach aims to advance the clinical application of its platelet production techniques, contributing to improved patient care in transfusion medicine.

StemRIM is a biotechnology company based in Ibaraki, Japan, founded in 2006. The company specializes in the development of regeneration-guided medicines aimed at treating challenging diseases such as epidermolysis bullosa, cerebral infarction, and myocardial infarction. StemRIM's innovative approach involves mobilizing the body's own stem cells to target injured or diseased tissues without the need for extraction. Their product portfolio includes PJ1 regeneration induction medicine using HMGB1 peptides, PJ2 and PJ3 regeneration-inducing drugs and proteins, as well as the PJ4 therapeutic autologous cell collection device and PJ5 stem cell gene therapy technology. Through its research and development efforts, StemRIM seeks to advance the field of regenerative medicine and provide effective treatment options for patients with intractable conditions.

Institution for a Global Society specializes in providing innovative assessment solutions designed for educational institutions and businesses. Its offerings include GROW Academy, DxGROW, Ai GROW, and GROW360, which aim to facilitate seamless and unbiased evaluation processes. The organization employs ethical technology to foster a sustainable learning and development environment for individuals throughout their lives. Additionally, it focuses on people analytics, helping organizations identify, recruit, and develop human capital effectively. Its predictive analytics software has gained traction among various entities, including multinational corporations, government agencies, and international institutions, highlighting its commitment to enhancing human resource capabilities and promoting lifelong learning.

REGiMMUNE Corporation is a biotechnology company based in Tokyo, Japan, with an office in San Francisco, California. Founded in 2006, it specializes in developing immune-regulatory therapeutics aimed at treating life-threatening diseases and disorders. The company utilizes its proprietary reVax technology, which induces regulatory T cells to promote immune tolerance against specific disease-causing antigens. REGiMMUNE's product pipeline includes RGI-2001, currently in a Phase I/II clinical trial for treating Graft versus Host Disease associated with hematopoietic stem cell transplantation, as well as RGI-3001, a preclinical candidate for type 1 diabetes. Its portfolio also addresses a range of conditions, including allergies, autoimmune diseases, and transplantation disorders, with a focus on reducing the side effects commonly associated with conventional immunosuppressants. The company's research efforts are directed towards developing innovative solutions for various immune system disorders, including rheumatoid arthritis, multiple sclerosis, and systemic lupus erythematosus.

Drivemode, Inc. is a technology company that specializes in enhancing the driving experience through its innovative mobile application. Founded in 2014 by former entrepreneurs from Zipcar and Tesla Motors, Drivemode focuses on providing a user-friendly platform that integrates various smartphone functions such as navigation, music, and messaging, all accessible via voice commands. This allows drivers to minimize distractions while on the road. The application analyzes driving patterns, calendar events, and recent communications to offer personalized navigation suggestions and facilitate seamless music control. Since its launch in 2015, the Drivemode app has achieved significant popularity, garnering over 1 million downloads globally. Based in Redwood City, California, Drivemode operates as a subsidiary of Honda R&D Co., Ltd. and continues to collaborate with key players in the connected car ecosystem to further advance its mission of promoting smarter, safer driving.

FLOSFIA INC. is a Tokyo-based company that specializes in developing corundum structured Gallium Oxide semiconductor power devices. Founded on March 31, 2011, as a spin-off from research at Kyoto University, the company focuses on film formation through mist chemical vapor deposition. FLOSFIA's products are characterized by high breakdown voltage and efficiency, aimed at creating low-loss power devices that leverage the advantageous properties of gallium oxide (Ga2O3).

Hacarus Inc. is a technology company based in Kyoto, Japan, that specializes in artificial intelligence solutions for the manufacturing and medical sectors. Established in 2014, Hacarus develops products that leverage its proprietary Sparse Modeling technology, which allows for efficient data analysis and decision-making. The company offers several key platforms, including SALUS, which caters to medical and life sciences applications, and COLIGO, a customizable application that supports various implementations in IoT and edge computing. Additionally, Hacarus provides SPECTRO, a tool for enhanced visual inspections, and offers data science consulting services along with an AI Academy for education in AI technologies. By focusing on small data and resource-efficient solutions, Hacarus aims to deliver insights that enable faster and more reliable decision-making compared to traditional deep learning approaches.

Kyoto Drug Discovery and Development Co. Ltd., based in Kyoto, Japan, specializes in the development of therapeutic drugs aimed at treating chronic degenerative eye diseases. The company focuses on innovative agents for conditions such as glaucoma, central retinal artery occlusion (CRAO), retinitis pigmentosa, and age-related macular degeneration (AMD), which are often considered incurable or intractable. By creating effective treatments for these serious conditions, Kyoto Drug Discovery and Development enables healthcare professionals to better diagnose and manage patients suffering from these debilitating eye diseases.

Integral Geometry Science Inc., founded in 2012 and based in Kobe, Japan, specializes in the design and development of advanced measurement devices and software for image data processing. The company focuses on the inverse analysis theory of electromagnetic and scattered fields, producing high-performance measurement systems that utilize multi-path scattered field theory. Integral Geometry Science is particularly noted for its microwave mammography system, which addresses challenges in imaging high-density breast tissue. This innovative technology improves the clarity of images, allowing for accurate differentiation between cancerous and normal tissue, thus reducing the need for painful and radiation-exposing conventional screening methods. Additionally, the company manufactures nondestructive inspection systems for lithium-ion batteries, contributing to safety and reliability in battery technology.

AFI Technology, established on December 23, 2013, in Seoul, Korea, specializes in manufacturing and selling innovative inspection and monitoring technology products primarily for the food and life science industries. The company offers electric filter separation technology and rapid detection systems that address microbial contamination risks, allowing clients to enhance food safety. With a strong emphasis on environmental responsibility, AFI responds to diverse needs in rapid microbiological testing and other technology solutions, underscoring its commitment to providing effective and efficient products for its clientele.

Farmship, Inc. is an AgriTech company based in Tokyo, Japan, founded in 2014. It specializes in agricultural food distribution services and develops sustainable agricultural systems through advanced technology. The company focuses on vertical farming, utilizing artificial intelligence and data analytics to optimize growing conditions for crops. This innovative approach allows for increased food production while minimizing resource usage and reducing the environmental impact of agriculture. In addition to its technological advancements, Farmship supports future agriculture through distribution, human resources, and business development initiatives.

Megakaryon Corporation is a medical research company based in Kyoto, Japan, with an additional office in Tokyo. Founded in 2011, it specializes in the development of blood products, particularly platelets and red blood cells, derived from human induced pluripotent stem (iPS) cell lines. The company focuses on creating transfusion medicine technologies that allow medical practitioners to maintain patients' platelet counts without relying on traditional blood donations. Megakaryon's innovative approach aims to advance the clinical application of its platelet production techniques, contributing to improved patient care in transfusion medicine.

Helpfeel is a technology company focused on human empowerment through knowledge delivery. It offers tools that facilitate access to information, including Frequently Asked Questions (FAQs), internal knowledge searches, and product recommendations. Helpfeel's platform allows users to refine and connect ideas, helping them find answers efficiently. The company aims to enhance user experience by simplifying the search for information, thereby fostering better understanding and communication. Established with a vision to improve knowledge accessibility, Helpfeel continues to innovate in the realm of information technology.

iHeart Japan Corporation focuses on developing regenerative medicinal products specifically aimed at treating severe heart failure. The company leverages iPSC (induced pluripotent stem cell) technology, originally developed by scientists at Kyoto University, to create innovative solutions that help patients avoid long wait times for heart transplants. Their primary product involves a cell sheet that can be attached to the heart, promoting the formation of a vascular network to enhance blood circulation and improve therapeutic outcomes. In addition to its core product, iHeart also offers healthcare contract and consulting services that support physicians in restoring cardiac function and potentially addressing other organ failures, such as those affecting the liver.

MONEY DESIGN Co., Ltd. is a fintech company based in Tokyo, Japan, founded in 2013. The firm specializes in asset management and investment advisory services, providing automated investment management solutions to its clients. By leveraging technology, MONEY DESIGN aims to simplify the investment process and make financial advice more accessible to a broader audience.